In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-α converting enzyme/tumor necrosis factor-α/nuclear factor-κB

被引:34
|
作者
Bigdeli, M. R. [1 ]
Khoshbaten, A. [2 ]
机构
[1] Shahid Beheshti Univ, Fac Biol Sci, Tehran, Iran
[2] Baqiyatallah Med Sci Univ, Res Ctr Chem Injuries, Tehran, Iran
关键词
ischemic preconditioning; ischemic tolerance; normobaric hyperoxia; NF-kappa B; TNF-alpha; TACE;
D O I
10.1016/j.neuroscience.2008.02.064
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies suggest that intermittent and prolonged normobaric hyperoxia (HO) results in brain ischemic tolerance (BIT), reducing ischemic brain injury. We have attempted to determine the time course of HO-induced BIT, and to explore the putative roles of tumor necrosis factor-alpha (TNF-alpha) converting enzyme TACE), TNF-alpha, and nuclear factor-kappa B (NF-kappa B) activation in mediating this effect. Two core experimental protocols were applied to rats (experiments 1 [E1] and 2 [E2] respectively). E1 rodents comprised six subgroups, breathing room air (RA; O-2=21%), or 95% oxygen (1-10) for 4, 8, 16 h (4RA, 8RA, 16RA and 4HO, 8HO, 16HO respectively). E2 rodents were divided into subgroups, exposed to 95% inspired HO for 4 h/day for six consecutive days (intermittent hyperoxia, InHO) or for 24 continuous hours (prolonged hyperoxia, PrHO). Each of these had a control group exposed to 21% oxygen in the same chamber. Twenty-four hours after pretreatment, each group was randomly divided to receive 60 min right middle cerebral artery occlusion (MCAO-operated), sham-operation (without MCAO), or no operation (intact). After 24 h reperfusion, neurologic deficit score (NDS), brain water content, Evans Blue extravasation (as a marker of blood-brain barrier permeability), TACE expression, serum TNF-alpha, and phosphor-kappa B alpha levels were assessed in all animals, and infarct volume in the MCAO-operated subgroups. E1: Compared with the control (RA) group, infarct volume was reduced by 58.6% and 64.4% in 16 h and 24 In respectively. NDS and Evans Blue extravasation was also reduced in 16 In and 24 h. There was no statistical difference among 4 h and 8 h. E2: Preconditioning with prolonged and intermittent HO decreased NDS, infarct volume and upregulated TACE and increased phosphor-kappa B alpha and serum TNF-alpha level significantly. Although further studies are needed to clarify the mechanisms of brain ischernic tolerance, InHO and PrHO may partly exert their effects via triggering TACE/TNF-alpha/NF-kappa B. (c) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:671 / 678
页数:8
相关论文
共 50 条
  • [41] Expression of tumor necrosis factor-α and nuclear factor-kappaB/RelA and the pathogenesis of psoriasis
    Moorchung, Nikhil
    Vasudevan, Biju
    Mani, N. S.
    Verma, Rajesh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2014, 57 (02) : 205 - 208
  • [42] A ginseng saponin metabolite suppresses tumor necrosis factor-α-promoted metastasis by suppressing nuclear factor-κB signaling in murine colon cancer cells
    Choo, Min-Kyung
    Sakurai, Hiroaki
    Kim, Dong-Hyun
    Saiki, Ikuo
    ONCOLOGY REPORTS, 2008, 19 (03) : 595 - 600
  • [43] Niaspan treatment increases tumor necrosis factor-α-converting enzyme and promotes arteriogenesis after stroke
    Chen, Jieli
    Cui, Xu
    Zacharek, Alex
    Ding, Guang Liang
    Shehadah, Amjad
    Jiang, Quan
    Lu, Mei
    Chopp, Michael
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 (05) : 911 - 920
  • [44] Propanil inhibits tumor necrosis factor-α production by reducing nuclear levels of the transcription factor nuclear factor-κB in the macrophage cell line IC-21
    Frost, LL
    Neeley, YX
    Schafer, R
    Gibson, LF
    Barnett, JB
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 172 (03) : 186 - 193
  • [45] Role of the protein kinase C λ/ι isoform in nuclear factor-κB activation by interleukin-1β or tumor necrosis factor-α:: Cell type specificities
    Bonizzi, G
    Piette, J
    Schoonbroodt, S
    Merville, MP
    Bours, V
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (06) : 713 - 720
  • [46] Tumor necrosis factor-α gene polymorphisms in relation to periodontitis
    Craandijk, J
    van Krugten, MV
    Verweij, CL
    van der Velden, U
    Loos, BG
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2002, 29 (01) : 28 - 34
  • [47] Effects of ultrasound on the structure and function of tumor necrosis factor-α
    Tian, ZM
    Wan, MX
    Wang, B
    Wang, SP
    Wu, XM
    Ruan, YS
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2003, 29 (09) : 1331 - 1339
  • [48] Tumor necrosis factor-α-induced inflammatory responses in cattle
    Kushibiki, Shiro
    ANIMAL SCIENCE JOURNAL, 2011, 82 (04) : 504 - 511
  • [49] Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration
    Wang, Cheng
    Yu, Xiaohua
    Yan, Yiguo
    Yang, Wei
    Zhang, Shujun
    Xiang, Yongxiao
    Zhang, Jian
    Wang, Wenjun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2017, 49 (01) : 1 - 13
  • [50] Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy
    Navarro-Gonzalez, Juan F.
    Jarque, Ana
    Muros, Mercedes
    Mora, Carmen
    Garcia, Javier
    CYTOKINE & GROWTH FACTOR REVIEWS, 2009, 20 (02) : 165 - 173